01628nas a2200397   4500000000100000008004100001260001700042653001500059653001000074653000900084653002200093653001400115653001300129653001000142653001900152653002100171653001700192653003000209653002000239653001100259653001100270653001800281653001200299653000900311653001600320653002100336653001800357653003000375100001600405245008100421300001000502490000700512050001600519520068100535022001401216       1998                            d  c1998 Jan-Mar10aAdolescent10aAdult10aAged10aAged, 80 and over10aBlindness10aCataract10aChild10aCohort Studies10aCorneal Diseases10aEye diseases10aEye Infections, Bacterial10aEyelid Diseases10aFemale10aHumans10aIris Diseases10aleprosy10aMale10aMiddle Aged10aVision Disorders10aVisual Acuity10aWorld Health Organization1 affytche T J00aThe prevalence of disabling ocular complications of leprosy: a global study.  a49-590 v70  aFFYTCHE19983 a<p>A world-wide study on the ocular complications of leprosy has been carried out over the past ten years. The data from 4772 patients, designed to give baseline information for a five-year incidence study, have been analysed. Blindness due to leprosy was seen in 3.2% of the sample and 7.1% had Grade 2 visual disability. The causes of visual impairment in the disease are discussed and it is emphasized that a high proportion of these are preventable, particularly through the early use of multidrug therapy. The active participation of ophthalmologists in the management of the disease is still required since many of the blinding complications respond well to surgery.</p>  a0254-9395